The Neuropsychiatric Inventory: assessing psychopathology in dementia patients - PubMed (original) (raw)
Review
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients
J L Cummings. Neurology. 1997 May.
Abstract
The Neuropsychiatric Inventory (NPI) was developed to assess psychopathology in dementia patients. It evaluates 12 neuropsychiatric disturbances common in dementia: delusions, hallucinations, agitation, dysphoria, anxiety, apathy, irritability, euphoria, disinhibition, aberrant motor behavior, night-time behavior disturbances, and appetite and eating abnormalities. The severity and frequency of each neuropsychiatric symptom are rated on the basis of scripted questions administered to the patient's caregiver. The NPI also assesses the amount of caregiver distress engendered by each of the neuropsychiatric disorders. A total NPI score and a total caregiver distress score are calculated, in addition to the scores for the individual symptom domains. Content validity, concurrent validity, inter-rater reliability, and test-retest reliability of the NPI are established. Different neurologic disorders have characteristic neuropsychiatric manifestations and distinctive NPI profiles. The NPI is sensitive to treatment effects and has demonstrated the amelioration of behavioral symptoms in Alzheimer's disease by cholinergic agents. The NPI is a useful instrument for characterizing the psychopathology of dementia syndromes, investigating the neurobiology of brain disorders with neuropsychiatric manifestations, distinguishing among different dementia syndromes, and assessing the efficacy of treatment.
Similar articles
- The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.
Stella F, Forlenza OV, Laks J, de Andrade LP, Avendaño MA, Sé EV, Cação Jde C, Lyketsos CG, de Medeiros K. Stella F, et al. Int Psychogeriatr. 2013 Sep;25(9):1503-11. doi: 10.1017/S1041610213000811. Epub 2013 Jun 14. Int Psychogeriatr. 2013. PMID: 23763895 Free PMC article. - Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, MacMillan A, Ketchel P, DeKosky ST. Kaufer DI, et al. J Am Geriatr Soc. 1998 Feb;46(2):210-5. doi: 10.1111/j.1532-5415.1998.tb02542.x. J Am Geriatr Soc. 1998. PMID: 9475452 - The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. Cummings JL, et al. Neurology. 1994 Dec;44(12):2308-14. doi: 10.1212/wnl.44.12.2308. Neurology. 1994. PMID: 7991117 - Neuropsychiatric assessment of Alzheimer's disease and related dementias.
Cummings JL, McPherson S. Cummings JL, et al. Aging (Milano). 2001 Jun;13(3):240-6. doi: 10.1007/BF03351482. Aging (Milano). 2001. PMID: 11444257 Review. - The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review.
Terum TM, Andersen JR, Rongve A, Aarsland D, Svendsboe EJ, Testad I. Terum TM, et al. Int J Geriatr Psychiatry. 2017 Jul;32(7):703-717. doi: 10.1002/gps.4704. Epub 2017 Mar 20. Int J Geriatr Psychiatry. 2017. PMID: 28317166 Review.
Cited by
- Varoglutamstat: Inhibiting Glutaminyl Cyclase as a Novel Target of Therapy in Early Alzheimer's Disease.
Feldman HH, Messer K, Qiu Y, Sabbagh M, Galasko D, Turner RS, Lopez O, Smith A, Durant J, Lupo JL, Revta C, Balasubramanian A, Kuehn-Wache K, Wassmann T, Schell-Mader S, Jacobs DM, Salmon DP, Léger G, DeMarco ML, Weber F; ADCS VIVA-MIND Study Group. Feldman HH, et al. J Alzheimers Dis. 2024;101(s1):S79-S93. doi: 10.3233/JAD-231126. J Alzheimers Dis. 2024. PMID: 39422941 Free PMC article. - Sex Differences in Neuropsychiatric Symptoms in Alpha-Synucleinopathies: A Systematic Review and Meta-Analysis.
Couture V, Carmel JF, Rousseau K, Létourneau G, Clerc D, Huot P, Forget MF, Nguyen QD, Camicioli R, Desmarais P. Couture V, et al. Mov Disord Clin Pract. 2024 Oct 9. doi: 10.1002/mdc3.14227. Online ahead of print. Mov Disord Clin Pract. 2024. PMID: 39385552 Review. - Feasibility of a person-centred multidimensional interdisciplinary rehabilitation programme in community-dwelling people with dementia: a randomised controlled pilot trial.
Hasselgren L, Conradsson M, Lampinen J, Toots A, Olofsson B, Nilsson I, Gustafsson M, Lindelöf N, Holmberg H, Gustafson Y, Littbrand H. Hasselgren L, et al. BMC Geriatr. 2024 Sep 28;24(1):794. doi: 10.1186/s12877-024-05372-9. BMC Geriatr. 2024. PMID: 39342131 Free PMC article. Clinical Trial. - Factors Associated with Increased Burden of Caregivers of People with Dementia with Lewy Bodies.
Toya S, Hashimoto M, Manabe Y, Yamakage H, Ikeda M. Toya S, et al. Geriatrics (Basel). 2024 Sep 9;9(5):115. doi: 10.3390/geriatrics9050115. Geriatrics (Basel). 2024. PMID: 39311240 Free PMC article. - Investigating patient eligibility for anti-amyloid monoclonal antibody treatment of Alzheimer's disease: real-world data from an Austrian psychiatric memory clinic population.
Defrancesco M, Gizewski ER, Mangesius S, Galijasevic M, Virgolini I, Kroiss A, Marksteiner J, Jehle J, Doganyigit B, Hofer A. Defrancesco M, et al. BJPsych Open. 2024 Sep 23;10(5):e160. doi: 10.1192/bjo.2024.747. BJPsych Open. 2024. PMID: 39308280 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical